Evolent Health Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Evolent Health hat ein Gesamteigenkapital von $1.2B und eine Gesamtverschuldung von $597.9M, wodurch sich der Verschuldungsgrad auf 48.6% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen $2.6B bzw. $1.4B. Evolent Health Das EBIT des Unternehmens beträgt $26.1M, so dass der Zinsdeckungsgrad 0.6 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von $165.1M.

Wichtige Informationen

48.4%

Verhältnis von Schulden zu Eigenkapital

US$598.78m

Verschuldung

Zinsdeckungsgrad1.3x
BargeldUS$101.25m
EigenkapitalUS$1.24b
GesamtverbindlichkeitenUS$1.24b
GesamtvermögenUS$2.48b

Jüngste Berichte zur Finanzlage

Recent updates

Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet

Sep 19
Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet

Evolent Health: Let The Bidding Begin

Aug 23

Potential Upside For Evolent Health, Inc. (NYSE:EVH) Not Without Risk

Jul 29
Potential Upside For Evolent Health, Inc. (NYSE:EVH) Not Without Risk

Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Jul 01
Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Evolent Health: Recent Pullback, A Buying Opportunity Or Not? (Rating Downgrade)

May 22

These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well

May 05
These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well

Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares

Apr 08
Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares

Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Mar 12
Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Jan 17
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)

Dec 21
Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)

Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital

Nov 30
Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital

A First Evaluation On Evolent Health

Oct 04

Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?

Sep 29
Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?

There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital

Sep 01
There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital

An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued

Aug 04
An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued

Evolent Health: Business Economics Still Appealing, Reiterate Buy

Jul 19

Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely

Jun 14
Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely

Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

May 30
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued

May 02
An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued

Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue

Apr 17
Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue

Evolent Health GAAP EPS of $0.11 beats by $0.13, revenue of $382.4M beats by $9.47M

Feb 22

Is Evolent Health (NYSE:EVH) A Risky Investment?

Feb 19
Is Evolent Health (NYSE:EVH) A Risky Investment?

Evolent Health: Strengthening Fundamentals, Investing At High Rates Of Return

Feb 15

Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?

Feb 01
Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?

Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger

Jan 14
Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger

Evolent spikes as Humana partnership expands

Jan 12

Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?

Dec 27
Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?

Evolent Health offered $23.5M class action securities settlement

Sep 19

Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Sep 18
Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Evolent Health: Improving Financials, But There's More

Aug 31

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: EVHDie kurzfristigen Aktiva des Unternehmens ($669.2M) übersteigen seine kurzfristigen Passiva ($659.0M).

Langfristige Verbindlichkeiten: EVHDie kurzfristigen Vermögenswerte des Unternehmens ($669.2M) decken seine langfristigen Verbindlichkeiten ($755.4M) nicht.


Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: EVHDie Nettoverschuldung im Verhältnis zum Eigenkapital (40.2%) wird als hoch angesehen.

Schulden abbauen: EVHDas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 19.4% auf 48.6% gestiegen.


Bilanz


Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: Obwohl EVH unrentabel ist, verfügt es über eine ausreichende Cash-Runway für mehr als 3 Jahre, wenn es seinen derzeitigen positiven freier Cashflow beibehält.

Vorhersage Cash Runway: EVH ist unrentabel, verfügt aber über eine ausreichende Liquiditätsreserve für mehr als drei Jahre, da der freie Cashflow positiv ist und um 40.7 % pro Jahr wächst.


Entdecken Sie finanziell stabile Unternehmen